Innovest Global Inc. (OTCMarkets:IVST) Is Executing Multiple Initiatives at the Corporate Level Which Will Result in the Platform it Needs for the Next Season of Growth
Innovest Global Inc. (OTCMarkets:IVST) (the "Company" or "Innovest"), is executing multiple initiatives at the corporate level which will result in the platform it needs for the next season of growth.Innovest Global Inc. (OtcMarkets:IVST) Advances Strategic Growth Plan for Innovest Energy Group
Innovest Global Inc. (OTCMarkets:IVST) (the "Company" or "Innovest"), hosted over twenty energy professionals as the Innovest Energy Group pushes forward with its growth plan.Innovest Global Inc: Strong Fundamental and Technical Analysis Puts Company in Great Position
Spotlight Growth has published new content on Innovest Global, Inc. (OTC PINK: IVST). Innovest Global, Inc. is a diversified holding company that focuses on acquiring niche, high-growth businesses that are capable of generating significant annual revenue. The company's planned subsidiaries operate across telehealth, biotech, building materials, commercial energy, business-to-business distribution, national call center and auto sales.Innovest Global Inc. Marks Its Fifth Acquisition of 2018 and Is Poised To Increase Its Annual Revenue to over Five-Times Its Current Rate with a Pending Acquisition of a $30 Million Revenue Company
Innovest Global Inc. (OTCMarkets:IVST) (the "Company" or "Innovest"), sales from its existing business units continue to grow, the Company now owns a 20% stake in StemVax Therapeutics, which has the worldwide exclusive rights to a brain cancer vaccine, which is patent protected. Innovest has announced a pending acquisition of a $30 million revenue company, which would mark its fifth acquisition of 2018, and increase the Company's annual revenue to over five-times its current rate.Innovest Global Inc. (OTC:IVST) Set to Add $30 Million in Annual Revenue with Pending Acquisition
Innovest Global Inc. (OTCMarkets:IVST) (the "Company" or "Innovest"), has signed a letter of intent, and agreed to final structure for the acquisition of a $30 million revenue company in the Building Materials Industry. This will add to its current operations in commercial and industrial products and services, and its recent biotech acquisition.Innovest Global Inc. (OTCMARKETS:IVST) Media Efforts Take Root Ahead of Developments as They Tie Up Their First Audit, Uplist, and New Acquisition Items
Innovest Global Inc. (OTCMarkets:IVST) (the "Company" or "Innovest"), a diversified holding company with operations in commercial and industrial products and services, energy, biotechnology and health services, is seeing results from its recent initiative to generate public interest in its accomplishments.Innovest Global Inc. (OTCMARKETS:IVST) Biotech Division Sets Fall Conference Schedule
Innovest Global Inc. (OTC Markets:IVST) (the "Company" or "Innovest") Biotechnology Division announced that it will be attending two conferences this fall to advance the objectives of StemVax Therapeutics, and to explore additional Biotech opportunities.Innovest Global Inc. Announces Its Call Center Revenue Has Doubled Since Its Acquisition, Shepherd Energy Seals $100k Plus Contract, C&I Division Pacing $4.5mm Revenue
Innovest Global Inc, (OTCMARKETS:IVST) A publicly traded operating company with diversified holdings in Commercial & Industrial, Energy, and Biotechnology & Health Services, Highlights is accomplishments for August 2018. The Company reports that their Call Center Revenue has doubled since the Acquisition, Shepherd Energy has landed a $100,000 Plus Contract, and the commercial and industrial Division Now Pacing $4,500,000 in Revenue.